China begins tests of first A/H1N1 flu vaccines
Laboratory tests began on China's first developed A/H1N1 flu vaccine
June 15.
The vaccines are expected to hit the market in September after 14
days of safety tests in labs and two-month clinical tests from July,
said, Deputy General Manager of Hualan Biological Engineering Inc. Fan
Bei, based in Henan Province.
The company had produced a first batch of 90,000 doses, but it would
be able to make 600,000 doses a day once it was approved, Fan said.
"As the vaccines still need to go through several tests, we did not
produce at full capacity", Fan said.
A clinical test plan submitted by the firm was approved by the State
Food and Drug Administration (SFDA), but she would not release the
details of the plan. The company received the seed virus from a World
Health Organization (WHO) lab on June 3.
China has 11 drug firms that are qualified to produce flu vaccines.
Another drug company, Sinovac Biotech Co. Ltd, announced that it had
started development of A/H1N1 flu vaccines on June 15.
Shanghaidaily.com
|